预测宫颈癌腹主动脉旁淋巴结转移扩大野放化疗所致严重血液学毒性
PURPOSE: The purpose of this study was to determine factors predictive for severe hematologic toxicity (HT) in cervical cancer patients with para-aortic lymph node metastasis treated with concurrent cisplatin chemoradiation to an extended field (EFCRT).…
要点
- 肥胖患者(n=12)尽管化疗剂量相当,发生HT3+的可能性更低(P = .03)。
- BMTOT和活性骨髓接受20、30、45 Gy的剂量体积及体重指数显著预测HT3+。
- HT3+患者治疗时间更长(62 vs 53天,P < .001)。
核心结论
- 对于接受扩大野放化疗的患者,骨髓照射参数和体重指数与HT3+相关。
- 已创建简化列线图预测HT3+,以便探索骨髓保护性照射技术。
研究设计与样本
- 活性骨髓定义为18F-FDG PET/CT上标准摄取值高于BMTOT平均值的照射野内总骨髓区域。
- 自放疗开始至结束每周血常规按CTCAE v4.0评估血液学毒性。
主要发现
- 肥胖患者(n=12)尽管化疗剂量相当,发生HT3+的可能性更低(P = .03)。
- BMTOT和活性骨髓接受20、30、45 Gy的剂量体积及体重指数显著预测HT3+。
- HT3+患者治疗时间延长(62 vs 53天,P < .001)。
临床怎么用
- 可利用骨髓照射参数和体重指数评估HT3+风险,并参考简化列线图。
- 对高风险患者可考虑探索骨髓保护性照射技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to determine factors predictive for severe hematologic toxicity (HT) in cervical cancer patients with para-aortic lymph node metastasis treated with concurrent cisplatin chemoradiation to an extended field (EFCRT). METHODS AND MATERIALS: Thirty-eight patients with cervical cancer and para-aortic lymph node metastasis who underwent EFCRT were analyzed. Active bone marrow was defined as the region within irradiated total bone marrow (BMTOT) with a standard uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography greater than the mean standard uptake value for BMTOT. Serial weekly blood counts from the beginning to the end of radiation treatment were evaluated for HT using Common Terminology Criteria for Adverse Events, version 4.0. RESULTS: Nineteen patients had grade 3 or higher hematologic toxicity (HT3+), not including lymphocyte toxicity. Obese patients (n = 12) were less likely to get HT3+ (P = .03) despite getting equivalent doses of chemotherapy. Volumes of BMTOT and active bone marrow receiving doses of 20, 30, and 45 Gy and body mass index significantly predicted HT3+. Patients who had HT3+ had prolonged treatment time (62 vs 53 days, P < .001). CONCLUSIONS: For patients receiving EFCRT, bone marrow irradiation parameters and patient body mass index were associated with HT3+. A simplified nomogram has been created to predict HT3+ in these patients, allowing the potential to explore bone marrow-sparing delivery techniques.
引用
- Yan K, Ramirez E, Xie XJ, et al. Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer. Pract Radiat Oncol. 2017. PMID: 28865761. doi:10.1016/j.prro.2017.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。